Porównaj metody

	Inwentarz Objawów Bólu Neuropatycznego (NPSI)	Skala Oceny Niepełnosprawności Migrenowej (MIDAS)
Dziedzina	Neurologia	Neurologia
Rodzina	Process / pipeline	Process / pipeline
Rok powstania	2004	1999
Twórca	Didier Bouhassira, INSERM, France	William F. Stewart, Johns Hopkins University
Typ	Self-report questionnaire	Self-report questionnaire
Źródło pierwotne	Bouhassira, D., Attal, N., Fermanian, J., Alchaar, H., Gautron, M., Masquet, B., Rostaing, S., Lanteri-Minet, M., Collin, E., Grisart, J., & Boureau, F. (2004). Development and validation of the Neuropathic Pain Symptom Inventory. Pain, 108(3), 248-257.	Stewart, W. F., Lipton, R. B., Dowson, A. J., & Sawyer, J. (1999). Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire. Neurology, 53(Suppl 3), S23-S28.
Inne nazwy	Neuropathic Pain Symptom Inventory, NPSI Scale	MIDAS Scale, Migraine Disability Assessment
Pokrewne	3	2
Podsumowanie	The NPSI is a 12-item self-report questionnaire specifically designed to assess and quantify the diverse symptoms characteristic of neuropathic pain. Developed by Bouhassira and colleagues in 2004, it evaluates five distinct symptom dimensions: burning pain, pressing pain, paroxysmal pain, evoked pain, and paresthesias. The NPSI is widely used in research and clinical practice to characterize neuropathic pain profiles, quantify symptom severity, and track treatment response.	The MIDAS is a brief, five-item self-report questionnaire that quantifies migraine-related disability by measuring days lost from work, school, household activities, and family/social activities over a 3-month period. Introduced by Stewart and colleagues in 1999, it is the most widely used measure of migraine burden in clinical practice and research. MIDAS directly translates migraine frequency and severity into functional impact (lost productivity, lost days), enabling healthcare providers and patients to understand the true disability burden of migraines.